Smith J, Kiupel M, Farrelly J, Cohen R, Olmsted G, Kirpensteijn J, Brocks B, Post G
Department of Medical Oncology, Chicago Veterinary Cancer Center, Chicago, IL, USA.
Diagnostic Center for Population and Animal Health, Michigan State University, East Lansing, MI, USA.
Vet Comp Oncol. 2017 Mar;15(1):36-45. doi: 10.1111/vco.12140. Epub 2015 Feb 3.
Grade II mast cell tumours (MCT) are tumours with variable biologic behaviour. Multiple factors have been associated with outcome, including proliferation markers. The purpose of this study was to determine if extent of surgical excision affects recurrence rate in dogs with grade II MCT with low proliferation activity, determined by Ki67 and argyrophilic nucleolar organising regions (AgNOR). Eighty-six dogs with cutaneous MCT were evaluated. All dogs had surgical excision of their MCT with a low Ki67 index and combined AgNORxKi67 (Ag67) values. Twenty-three (27%) dogs developed local or distant recurrence during the median follow-up time. Of these dogs, six (7%) had local recurrence, one had complete and five had incomplete histologic margins. This difference in recurrence rates between dogs with complete and incomplete histologic margins was not significant. On the basis of this study, ancillary therapy may not be necessary for patients with incompletely excised grade II MCT with low proliferation activity.
II级肥大细胞瘤(MCT)是具有可变生物学行为的肿瘤。多种因素与预后相关,包括增殖标志物。本研究的目的是确定手术切除范围是否会影响由Ki67和嗜银核仁组织区(AgNOR)确定的具有低增殖活性的II级MCT犬的复发率。对86只患有皮肤MCT的犬进行了评估。所有犬均接受了MCT的手术切除,其Ki67指数较低且联合AgNORxKi67(Ag67)值较低。在中位随访期内,23只(27%)犬出现局部或远处复发。在这些犬中,6只(7%)出现局部复发,1只切缘完整,5只切缘组织学不完整。切缘组织学完整和不完整的犬之间的复发率差异不显著。基于本研究,对于具有低增殖活性的II级MCT切除不完全的患者,可能不需要辅助治疗。